El interés en corto de Cardiol Therapeutics da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Cardiol Therapeutics. Los datos de interés en corto se actualizan cada dos semanas.

Cardiol Therapeutics (NASDAQ:CRDL) Bolsa, Informe de interés en corto

Cardiol Therapeutics

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Cardiol Therapeutics Inc. - Class A Common Shares

Cardiol Therapeutics Inc

Honda Motor Co., Ltd. ("Honda") and Nissan Motor Co., Ltd., ("Nissan"; Honda and Nissan are collectively referred to as the "Companies") have agreed to begin discussions and consideration toward a business integration (the "Business Integration") and have resolved at the boards of directors of each of the Companies to sign a memorandum of understanding regarding the consideration of the Business Integration, which has been duly executed
&nbsp;
<a href="https://global.honda/en/investors/library/filings/filings2024122301/main/0/link/CY2024_20241223_TSEfling_e_1_v1.pdf" title="https://global.honda/en/investors/library/filings/filings2024122301/main/0/link/CY2024_20241223_TSEfling_e_1_v1.pdf">https://global.honda/en/investors/library/filings/filings2024122301/main/0/link/CY2024_20241223_TSEfling_e_1_v1.pdf</a>

News

NSANY

Honda, Nissan Earlier Announced Talks On Potential Business Integration; Honda, Nissan: Plan to Sign Definitive Merger Agreement in June 2025

The Future Fund Managing Partner Gary Black on Sunday said that a majority of Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) car owners will likely not want to put their cars into the <a href="https://www.benzinga.com/topic/tesla-robotaxi">company&#8217;s robotaxi fleet</a>.
What Happened: &#8220;What % of Tesla owners would accept a stream of payouts from Tesla for deploying their cars in a TSLA robotaxi network to move people/luggage around every day?&#8221; Black posted on social media platform X while opining that over 50% will likely not want to rent their cars to Tesla&#8217;s robotaxi fleet.
Tesla CEO Elon Musk expects his company&#8217;s robotaxi fleet to function like a&nbsp;<a href="https://www.benzinga.com/news/24/04/38396288/teslas-robotaxi-to-be-called-cybercab-elon-musk-says-self-driving-fleet-will-be-like-combination-of" target="_blank" rel="noreferrer noopener">combination of Airbnb and Uber</a>. While a certain portion of the fleet will be owned by Tesla, individual customers can also add or subtract their vehicles to the robotaxi fleet at will for added earnings. As for riders, they can summon a car using the Tesla App, Musk said during the company's second-quarter earnings call in July. 
If Tesla charged $1 for every mile on a robotaxi ride and gave a 75% payout to car owners and every car had 25 trips every day with every trip being roughly 6 miles long, car owners could make roughly $40,000 per year by simply renting their car to the fleet, Black said while retaining his pessimism for users not wanting to rent their cars to the company fleet. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">What % of Tesla owners would accept a stream of payouts from Tesla for deploying their cars in a TSLA robotaxi network to move people/luggage around every day? At 25 trips/day x 6 miles/trip x $1/mile x 75% payout, let's assume a TSLA owner could make $40K per year by renting…
&mdash; Gary Black (@garyblack00) <a href="https://twitter.com/garyblack00/status/1870855355229438099?ref_src=twsrc%5Etfw">December 22, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Black is not alone in his doubts regarding Musk&#8217;s vision for his robotaxi fleet. In August, Uber Technologies Inc. CEO Dara Khosrowshahi <a href="https://www.benzinga.com/news/24/08/40299293/uber-ceo-dara-khosrowshahi-doubts-teslas-robotaxi-fleet-management-plans-but-maintains-hope-for-part">expressed doubts</a> about whether a car owner is going to want his car to be ridden in by a complete stranger. Tesla drivers will also likely want their car at the time when ridership is high, creating trouble in meeting demand, he said on an episode of The Logan Bartlett Show.
Building cars and operating a taxi fleet are "very very different" businesses, the Uber CEO then noted. While running a fleet, the company has to match people with their rides, and price the rides economically while also addressing other concerns like people getting sick in a car, losing items, or getting involved in accidents, he said.
Why It Matters: Tesla CEO&nbsp;Elon Musk&nbsp;said during Tesla's third-quarter earnings call that the company expects to start a ride-hail service in Texas and California starting next year,&nbsp;<a href="https://www.benzinga.com/news/24/10/41484511/palo-alto-may-open-streets-to-tesla-robotaxis-but-california-regulators-will-decide-fate" target="_blank" rel="noreferrer noopener">subject to regulatory approval</a>, with self-driving Model 3 and Model Y vehicles equipped with future versions of its full self-driving (FSD) driver assistance technology. While FSD currently requires active driver supervision, Musk and Tesla are hopeful that it can enable autonomous driving with future updates.
However, the vehicles might not all operate as driverless robotaxis initially in California and Texas but with a driver as some states demand it until the company touches certain milestones in terms of miles and hours driven, the company then said.
Last week, Bloomberg reported that Tesla is in <a href="https://www.benzinga.com/markets/equities/24/12/42575664/tesla-reportedly-in-talks-with-austin">early discussions with authorities in the city of Austin</a>, Texas, to roll out its&nbsp;autonomous vehicles for testing&nbsp;as early as 2025.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/24/12/42640472/tesla-exec-bemoans-cost-of-sending-letter-to-owners-affected-by-ev-giants-recent-recall-of-nearly-700000-vehicles">Tesla Exec Bemoans Cost Of Sending Letter To Owners Affected By EV Giant&#8217;s Recent Recall Of Nearly 700,000 Vehicles</a></li>
</ul>
Photo courtesy: Tesla

Analyst Color

Tech

TSLA

Tesla Analyst Estimates Vehicle Owners Can Make $40,000 A Year By Renting EVs To Robotaxi Fleet That Elon Musk Likened To A Combination Of Airbnb And Uber, But Will It Take Off?

Leading Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) analysts Dan Ives and Gary Black revealed stark differences in their valuation approaches during a recent &#8220;Brighter with Herbert&#8221; show appearance, even as both remain bullish on the electric vehicle maker&#8217;s prospects.
What Happened: Ives, Managing Director at Wedbush Securities, maintains the Street&#8217;s highest price target of $515 with a bull case of $650, citing potential revenues from autonomous robotaxis and the company&#8217;s Optimus robot project. He projects Tesla&#8217;s earnings at $15 per share by 2030.
&#8220;The Tesla story changes because everything we looked at with robotaxi gets accelerated,&#8221; Ives <a href="https://www.youtube.com/watch?v=HgFLEO4UiJ8">said</a>, estimating autonomous vehicles could capture 20% of ride-shares by decade&#8217;s end. He values Tesla&#8217;s autonomous business alone at $1 trillion.
In contrast, Black, Managing Partner at The Future Fund LLC, takes a more conservative approach with a $380 target, well above the Street average of $275. Black forecasts $17 earnings per share by 2030 but excludes robotaxi and Optimus revenue from his calculations.
&#8220;Even if I assume Tesla took 25% of ride-sharing market share, that only adds about a dollar per share in earnings,&#8221; Black explained, noting his use of higher risk adjustments in Tesla&#8217;s valuation given its volatility.
See Also: <a href="https://www.benzinga.com/markets/equities/24/12/42640010/palantir-and-anduril-reportedly-lead-consortium-partner-with-spacex-and-openai-to-compete-against-traditional-defense-contractors-in-850-billion-us-military-market">Palantir And Anduril Reportedly Lead Consortium, Partner With SpaceX And OpenAI To Compete Against Traditional Defense Contractors In $850 Billion US Military Market</a>
Why It Matters: The valuation debate comes as Tesla&#8217;s stock has surged nearly 71% year-to-date, recently crossing the symbolic $420 level that CEO Elon Musk referenced in his controversial 2018 &#8220;funding secured&#8221; tweet. Morgan Stanley has named Tesla its top stock pick for 2025, citing the company&#8217;s advances in <a href="https://www.benzinga.com/24/12/42452806/teslas-red-hot-stock-meets-meme-magic-420-level-musk-celebrates-the-prophecy-analysts-react">autonomy and robotics</a>.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Am considering taking Tesla private at $420. Funding secured.
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1026872652290379776?ref_src=twsrc%5Etfw">August 7, 2018</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Both analysts expressed optimism about Tesla&#8217;s planned entry into the compact car segment, with Black suggesting a $25,000-$30,000 hatchback could expand Tesla&#8217;s market reach similar to how the Model Y boosted its presence in the crossover segment.
Tesla has a consensus target of $280.41 from 33 analysts, according to <a href="https://www.benzinga.com/quote/TSLA/analyst-ratings">data from Benzinga Pro</a>. The high is $515, and the low is $24.86. Recent ratings from Baird, Mizuho, and Goldman Sachs give an average target of $446.67, implying a 3.05% upside.
Year-to-date, the Tesla stock has gained 69.50%.
<figure class="wp-block-image aligncenter size-large is-resized"><a href="https://www.benzinga.com/quote/TSLA/analyst-ratings"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23043001/Screenshot-2024-12-23-at-2.58.00%E2%80%AFPM-1024x371.png" alt="" class="wp-image-703695" style="width:684px;height:auto" /></a></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42639737/trumps-call-to-reclaim-panama-canal-sparks-backlash-every-square-meter-belongs-to-panama-says-president-mulino">Trump&#8217;s Call To Reclaim Panama Canal Sparks Backlash: &#8216;Every Square Meter Belongs To Panama,&#8217; Says President Mulino</a></li>
</ul>
Image Via Shutterstock 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Markets

TSLA Stock Valuation Duel: Dan Ives Bets Big On Robotaxis While Gary Black Plays It Safe

<a href="https://x.com/KeilafOmer/status/1870878159782174735" title="https://x.com/KeilafOmer/status/1870878159782174735">https://x.com/KeilafOmer/status/1870878159782174735</a>

INVZ

Innoviz Technologies CEO Omer Keilaf Tweeted Sunday,  "...we wanted to give you heads up towards a big announcement we are going to share tomorrow pre-market"

Himax Technologies, Inc. ("Himax" or "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>), an industry leader in fabless display driver ICs and other semiconductors, today announced that the Company and its AI ecosystem partners will unveil a suite of innovative, production-ready AIoT applications at CES 2025, powered by Himax's groundbreaking ultralow power WiseEye Module solutions. These designs will showcase intuitive, user-friendly AI capabilities set to transform multiple industries by improving productivity, scalability, automation, and efficiency, all while delivering better performance and lower power consumption. Himax's ultralow power WiseEye Module solutions are leading the AIoT revolution with their advanced, efficient, and scalable AI-driven technologies.
The Himax WiseEye Module seamlessly integrates ultralow power WiseEye AI processors and proprietary always-on CMOS sensors, designed with compact form factors, high integration, and plug-and-play functionality. Characterized by remarkably low power consumption at just single-digit milliwatts, it is ideal for battery-powered endpoint devices that cater to everyday life. The WiseEye Module incorporates versatile AI models from in-house or third-party partners, enabling no-code/low-code AI development for use cases like people counting, gesture recognition, human detection, face recognition, and audio command classification. This simplifies the AI development process, reducing cost and time, allowing AI developers, even those with limited AI expertise, to easily integrate advanced AI features into their systems and applications. Given their versatility, WiseEye Modules are poised to become foundational technology for a wide range of IoT applications.
At the event, a visionary and innovative lineup of ultralow power WiseEye Module solutions will be on display, showcasing their potential to revolutionize AI-powered applications across industries.

HIMX

Himax To Showcase AI-Powered Smart Tech Revolution at CES 2025

Smith &amp; Wesson Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) faces increased legal scrutiny as Mexico&#8217;s landmark lawsuit against U.S. gun manufacturers reaches a critical juncture at the Supreme Court, potentially creating new liability risks for the firearms industry.
What Happened: The lawsuit, filed in 2021, alleges that Smith &amp; Wesson and other defendants enabled gun trafficking to Mexican drug cartels through their business practices. According to ATF data <a href="https://www.cbsnews.com/news/guns-from-us-ending-up-in-mexico-60-minutes/">reviewed</a> by CBS News, an estimated 200,000 to 500,000 U.S. firearms are smuggled into Mexico annually, with 75% of confiscated weapons originating from the United States.
The case challenges traditional liability protections enjoyed by gun manufacturers under U.S. law. Mexico&#8217;s legal strategy, spearheaded by attorney Jonathan Lowy, argues that manufacturers are &#8220;aiding and abetting&#8221; gun trafficking by continuing to supply dealers with questionable sales patterns.
See Also: <a href="https://www.benzinga.com/markets/equities/24/12/42640010/palantir-and-anduril-reportedly-lead-consortium-partner-with-spacex-and-openai-to-compete-against-traditional-defense-contractors-in-850-billion-us-military-market">Palantir And Anduril Reportedly Lead Consortium, Partner With SpaceX And OpenAI To Compete Against Traditional Defense Contractors In $850 Billion US Military Market</a>
Why It Matters: Smith &amp; Wesson has denied the allegations as &#8220;not true.&#8221; The firearms industry has petitioned the Supreme Court, arguing that allowing such lawsuits could subject manufacturers to costly litigation from foreign entities attempting to influence U.S. gun control policies.
The lawsuit&#8217;s scope extends beyond manufacturers to include five Arizona-based gun dealers. Internal ATF documents revealed that 566 guns recovered in Mexico over a four-and-a-half-year period were traced to these dealers, with nearly 200 coming from a single retailer near Phoenix.
Aside from the Mexico lawsuit, Smith &amp; Wesson has also faced challenging market conditions weighing on its earnings &#8211; the company attributed its <a href="https://www.benzinga.com/news/24/09/40748035/smith-wesson-brands-reports-downbeat-results-joins-planet-labs-pbc-broadcom-and-other-big-stocks-mov">weaker second-quarter earnings</a> to inflationary pressures impacting consumers&#8217; spending.
Price Action: Smith &amp; Wesson Brands Inc. closed on Friday at $10.04, declining 1.47%. Over the past month, the stock has dropped 27.1%, according to <a href="https://www.benzinga.com/pro/">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42639737/trumps-call-to-reclaim-panama-canal-sparks-backlash-every-square-meter-belongs-to-panama-says-president-mulino">Trump&#8217;s Call To Reclaim Panama Canal Sparks Backlash: &#8216;Every Square Meter Belongs To Panama,&#8217; Says President Mulino</a></li>
</ul>
Image via Wikimedia Commons
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

SWBI

Smith & Wesson's Fate Hangs In The Balance As Supreme Court Weighs Mexico's Gun Trafficking Lawsuit: SWBI Stock Down 27% Over Past Month, Here's What's Next

The CNN Money Fear and Greed index showed some easing in the fear level, with the index moving to the &#8220;Fear&#8221; zone on Friday.
U.S. stocks settled higher on Friday, with the Dow Jones index surging almost 500 points during the session.
Even as the major indices recorded gains on Friday, all three averages fell last week. The Dow dipped around 2.3% to record its third losing week in a row. The S&amp;P 500 declined about 2%, while the Nasdaq Composite fell around 1.8% last week.
On the economic data front, the U.S. personal consumption expenditures price index rose 0.1% month-over-month in November down from 0.2% in each of the prior two months and compared to market estimates of 0.2%. The University of Michigan consumer sentiment rose to 74 in December, recording the highest level since April, versus a reading of 71.8 in November.
Carnival Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) reported better-than-expected earnings for its fourth quarter on Friday.
All sectors on the S&amp;P 500 closed on a positive note, with utilities, real estate, and information technology stocks recording the biggest gains on Friday.
The Dow Jones closed higher by around 498 points to 42,840.26 on Friday. The S&amp;P 500 rose 1.09% to 5,930.85, while the Nasdaq Composite surged 1.03% to close at 19,572.60 during Friday's session.
Investors are awaiting earnings results from Limoneira Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>), Bridgeline Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>), and Anavex Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 28.1, the index moved to the &#8220;Fear&#8221; zone on Friday, versus a prior reading of 21.9.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42616196/jim-cramer-likes-walmart-recommends-buying-this-very-very-good-financial-stock">Jim Cramer Likes Walmart, Recommends Buying This &#8216;Very, Very Good&#8217; Financial Stock</a></li>
</ul>
Photo courtesy: Shutterstock

Pre-Market Outlook

AVXL

BLIN

LMNR

Dow Jumps Around 500 Points But Records 3rd Straight Weekly Loss: Greed Index Moves To 'Fear' Zone

Steve Ballmer, the former Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) CEO, has bet heavily on the tech giant, which accounts for more than 80% of his investment portfolio. The result? His approach has paid off handsomely.
What Happened: In a Q&amp;A <a href="https://www.wsj.com/finance/investing/steve-ballmer-the-non-investing-guru-of-investing-b0058c11">with</a> The Wall Street Journal that was published on Sunday, Ballmer shared that over 80% of his holdings are tied to his former company, Microsoft, with the remainder invested in stock index funds.
He attributes his financial success to Microsoft&#8217;s strong performance, particularly after the AI boom sparked by Microsoft-backed OpenAI&#8217;s ChatGPT in November 2022.
"Microsoft's outperformed just about every other asset I could have owned," he stated, adding, "It's a little hard to say that it hasn't worked out."
See Also: <a href="https://www.benzinga.com/tech/24/12/42608964/samsung-one-ui-6-1-1-update-is-turning-this-galaxy-series-phones-into-paperweights-bricking-random-reboots-and-overheating-reported?itm_source=parsely-api">Samsung One UI 6.1.1 Update Is Turning This Galaxy Series Phones Into Paperweights: Bricking, Random Reboots And Overheating Reported</a>
Ballmer <a href="https://www.benzinga.com/markets/24/12/42638406/tech-titans-triumph-the-top-10-billionaires-who-made-big-gains-in-2024">holds a 4.5% stake in Microsoft</a>. Since 2020 till now, Microsoft has returned an average of 28.37% annually, significantly outperforming the S&amp;P 500's average return of around 11.08%.
When Ballmer was asked if his strategy applies to everyday investors, he said, &#8220;I'd suggest keeping it simple—unless you're truly committed to becoming an expert.&#8221;
Microsoft currently has a market capitalization of $3.346 trillion, making it the third most valuable company in the world. According to <a href="https://benzinga.grsm.io/lxquj26b2sag">data from Benzinga Pro</a>, Microsoft shares have risen by 17.72% year-to-date.
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: Ballmer&#8217;s strategy is influenced by Warren Buffett, who recommends S&amp;P 500 index funds <a href="https://www.benzinga.com/startups/24/10/41252767/warren-buffetts-timeless-advice-is-to-invest-in-stocks-that-youd-be-perfectly-happy-to-hold-if-the-m">for retail investors</a>.
Now worth $151 billion, according <a href="https://www.bloomberg.com/billionaires/">to</a> the Bloomberg Billionaire Index, Ballmer also has a significant investment in the Los Angeles Clippers, which has appreciated since his $2 billion purchase in 2014, now <a href="https://www.forbes.com/teams/los-angeles-clippers/">valued</a> at $5.5 billion.
Earlier this year, <a href="https://www.benzinga.com/markets/equities/24/07/39588200/bill-gates-hired-steve-ballmer-as-the-first-business-manager-at-microsoft-and-now-is-behind-him-">Ballmer&#8217;s wealth briefly surpassed</a> that of Microsoft co-founder Bill Gates. However, at the time of writing, Gates is at number seven on the list with a net worth of $160 billion, ahead of Ballmer.
Check out more of Benzinga's Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/24/12/42609242/marques-brownlee-breaks-down-how-googles-ai-video-generator-veo2-outpaces-openais-sora?itm_source=parsely-api">Marques Brownlee Breaks Down How Google&#8217;s AI Video Generator Veo2 Outpaces OpenAI&#8217;s Sora</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Microsoft

Media

MSFT

Steve Ballmer's Winning Investment Strategy: Billionaire Says 'Keep It Simple' As His Microsoft Bet Pays Off Thanks To AI Boom

Goldman Sachs analyst Allen Chang initiates coverage on Pony AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) with a Buy rating and announces Price Target of $19.6.

Price Target

Initiation

Analyst Ratings

PONY

Goldman Sachs Initiates Coverage On Pony AI with Buy Rating, Announces Price Target of $19.6

&nbsp;Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its stock will be added to the Nasdaq Biotechnology Index (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBI#NASDAQ">NBI</a>). The addition comes as a part of the annual reconstitution of the index. Alvotech's inclusion in the NBI will be effective when the U.S. market opens on Monday, December 23, 2024.

Government

Regulations

ALVO

Alvotech Joins Nasdaq Biotech Index, Effective Today

As the largest publicly traded dedicated non-operator, NOG has a large pipeline of acquisition opportunities and the Company frequently sends expressions of interest to acquire assets or businesses in order to evaluate and conduct due diligence on potential opportunities. Many of these requests to conduct diligence are rejected. The Company is not currently engaged in formal negotiations to acquire Granite Ridge.

Reported Friday, NOG Addressed Speculation On Granite Ridge Acquisition, Confirms No Formal Negotiations

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Limoneira Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) to report a quarterly loss at 7 cents per share on revenue of <a href="https://www.benzinga.com/quote/LMNR/earnings">$42.45 million after</a> the closing bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Limoneira shares gained 2% to $26.83 in after-hours trading.</li>
<li>Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) bagged a key win in its legal battle against semiconductor design company Arm Holdings Plc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>). A federal jury in Delaware ruled that Qualcomm did not violate its licensing agreement with Arm, clearing a hurdle for the San Diego, California-<a href="https://www.benzinga.com/24/12/42633922/qualcomm-bags-win-in-chips-licensing-trial-against-arm-but-the-battle-is-not-over-yet">headquartered chipmaker</a>. Qualcomm shares gained 1.9% to $155.72 in the after-hours trading session.</li>
<li>Analysts expect Anavex Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) to post a quarterly loss at 16 cents per share before the opening bell. Anavex Life Sciences shares gained 0.2% to $8.65 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Brenmiller Energy Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNRG#NASDAQ">BNRG</a>) shares rose sharply in after-hours trading on Friday after the company said it was awarded ISO/IEC 27001:2022 certification. Brenmiller Energy shares surged 12% to $0.8440 in the after-hours trading session.</li>
<li>Analysts expect Bridgeline Digital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) to post a quarterly loss at 5 cents per share on revenue of $3.87 million after the closing bell. Bridgeline Digital shares fell 0.7% to $1.48 in after-hours trading.</li>
</ul>
Check This Out:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42616196/jim-cramer-likes-walmart-recommends-buying-this-very-very-good-financial-stock">Jim Cramer Likes Walmart, Recommends Buying This &#8216;Very, Very Good&#8217; Financial Stock</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Trading Ideas

BNRG

QCOM

Qualcomm, Limoneira And 3 Stocks To Watch Heading Into Monday

SGML

Reported Friday, Sigma Lithium Secures Unanimous Approval For Triple Environmental License At Barreiro Mine

Fund manager Stephen Yiu of Blue Whale Growth Fund has forecasted that&nbsp;Broadcom Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) will yield substantial returns for investors by 2025, potentially surpassing AI chip heavyweight&nbsp;Nvidia Corporation&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
What Happened: Yiu said that tech giants like Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Google LLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), and Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) are looking to broaden their AI chip supplier base. Despite their substantial purchases of Nvidia&#8217;s GPUs, these companies are now also creating their own custom chips for AI applications, CNBC<a href="https://www.cnbc.com/2024/12/23/-the-next-nvidia-broadcom-is-the-ai-chip-stock-to-own-in-2025-investor-says.html"> reported</a> on Monday.
Yiu sees Broadcom as&nbsp;the next Nvidia in terms&nbsp;of potential outperformance, thanks to its strong partnerships with major tech firms. 
&#8220;Nvidia's&nbsp;GPUs are very powerful, but&nbsp;at the same time also&nbsp;very expensive,&#8221; Yiu noted. &#8220;From&nbsp;Microsoft's perspective, you don't want&nbsp;to become overly dependent on&nbsp;one single supplier.&#8221;
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/12/42624559/warren-buffett-says-a-surge-in-people-doing-big-dumb-things-is-tied-to-historically-easy-access-to-other-peoples-money?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Warren Buffett Says A Surge In People Doing &#8216;Big Dumb Things&#8217; Is Tied To Historically Easy Access To Other People&#8217;s Money</a>
Broadcom&#8217;s year to date returns have climbed 103.42% this year, as of Monday pre-market hours, according to <a href="https://pro.benzinga.com">Benzinga Pro</a>. It hit a market cap of over $1 trillion after announcing that its AI revenue&nbsp;tripled to $12.2 billion in&nbsp;2024. The company is working&nbsp;with three major cloud computing&nbsp;customers, Meta, Alphabet, and ByteDance, to develop custom AI chips.
Despite still holding an investment in Nvidia, Yiu has significantly cut it from nearly 10% of his fund's portfolio. He views Broadcom as a more attractive investment opportunity due to its smaller size. 
&#8220;For&nbsp;a $1 trillion company to&nbsp;grow 50% to become $1.5&nbsp;trillion is reasonable. But for&nbsp;Nvidia to do that, they&nbsp;would need to add another&nbsp;$1.5 trillion, which is a&nbsp;very big number,&#8221; he elaborated.
Why It Matters: Broadcom&#8217;s CEO Hock Tan has <a href="https://www.benzinga.com/trading-ideas/movers/24/12/42613368/broadcom-expects-decade-long-ai-chip-boom-as-big-tech-invest-billions">expressed strong confidence</a> in the sustainability of the AI boom. Big tech companies like Google, Meta, and ByteDance are investing heavily in designing custom processors to accelerate the training and deployment of AI systems. Even OpenAI and Apple have partnered with Broadcom to develop their AI server chips, diversifying their exposure to Nvidia.
Kurv Investment Management&#8217;s CEO Howard Chan recently mentioned that chipmakers like <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42600155/exclusive-nvidia-broadcom-tipped-to-dominate-ai-compute-wave-by-kurv-ceo">Nvidia and Broadcom </a>are leading the AI wave. He noted that demand is outstripping supply in this sector, benefiting chipmakers and cloud computing service providers.
Former House Speaker Nancy Pelosi (D-Calif.), known for her active stock market investments as a member of Congress, disclosed in June that she had <a href="https://www.benzinga.com/news/24/09/40692177/whats-going-on-with-broadcom-shares-today" target="_blank" rel="noreferrer noopener">acquired call options on Broadcom. </a>These options, adjusted to a strike price of $80 after a 10-for-1 stock split, are set to expire in June 2025.
Pelosi, a widely followed Congressional trader, has drawn <a href="https://www.benzinga.com/news/24/09/40692177/whats-going-on-with-broadcom-shares-today">significant attention to her stock holdings,</a> inspiring dedicated Pelosi portfolio trackers. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42628397/bitcoin-ethereum-xrp-dogecoin-recover-from-days-losses-if-this-is-the-christmas-sell-off-and-the-top-so-be-it-trader-says?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, XRP, Dogecoin Recover From Day&#8217;s Losses: &#8216;If This Is The Christmas Sell Off And The Top, So Be It,&#8217; Trader Says</a></li>
</ul>
Image via Shutterstock

General

AMZN

AVGO

GOOGL

NVDA

Is This Nancy Pelosi's Stock Pick Set To Overtake Nvidia? AI Chip Race To Heat Up By 2025 As Meta And Microsoft Look Beyond Jensen Huang's Chip Maker, Says Expert

<h3>Companies Reporting Before The Bell</h3>
• Anavex Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) is expected to report earnings for its fourth quarter. 
<h3>Companies Reporting After The Bell</h3>
• Bridgeline Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $3.87 million. 
• Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) is expected to report quarterly loss at $0.07 per share on revenue of $42.45 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Scheduled For December 23, 2024

WHLM

Reported Friday, Wilhelmina International Confirms Nasdaq Delisting, Last Trading Day Expected December 31, 2024

GLDG

Reported Friday, GoldMining Renews At-The-Market Program For Up To $50M In Common Shares

Macro Economic Events

Econ #s

Economics

U.K. Gross Domestic Product (YoY) For Q3 0.9% Vs. 1.0% Est.; 0.7% Prior

U.K. Gross Domestic Product (QoQ) For Q3 0.0% Vs. 0.1% Est.; 0.4% (Revised) Prior

U.K. Current Account For Q3 -18.1B Vs. -22.9B Est.; 24.0B (Revised) Prior

Cardiol Therapeutics (TSE:CRDL) has released an update. Cardiol Therapeutics Inc., a clinical-stage company specializing in heart disease treatment...

Cardiol Therapeutics Announces Public Share Offering

Cardiol Therapeutics (TSE:CRDL) has released an update. Cardiol Therapeutics, a clinical-stage life sciences company, has announced the pricing of ...

Cardiol Therapeutics Sets Common Share Offering Price

Cardiol Therapeutics (TSE:CRDL) has released an update. Cardiol Therapeutics, a clinical-stage company specializing in heart disease treatments, ha...

Cardiol Therapeutics Secures $13.5M in Public Offering

Cardiol Therapeutics (TSE:CRDL) has released an update. Cardiol Therapeutics has successfully completed a public offering, raising $15.525 million ...

Cardiol Therapeutics Raises $15.5 Million in Offering

Cardiol Therapeutics (CRDL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Edward Nash...

Cardiol Therapeutics' Strategic Advancements Boost Market Potential and Revenue Projections

Roth MKM analyst Jason Wittes maintained a Buy rating on Cardiol Therapeutics (CRDL – Research Report) today and set a price target of $10.00. The ...

Cardiol Therapeutics (CRDL) Gets a Buy from Roth MKM

Cardiol Therapeutics (TSE:CRDL) has released an update. Cardiol Therapeutics reports a significant net loss of $28.5 million for the nine months en...

Cardiol Therapeutics Faces Rising Losses and Falling Assets

Cardiol Therapeutics (TSE:CRDL) has released an update. Cardiol Therapeutics has announced promising results from its Phase II MAvERIC-Pilot study,...

Cardiol Therapeutics Reports Promising Phase II Results

Edward Nash Reaffirms Buy Rating for Cardiol Therapeutics: Positive Phase II Data and Strategic Future Trials Boost Market Potential

H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Cardiol Therapeutics (CRDL – Research Report) today and set a price target of ...

Vernon Bernardino Issues Buy Rating on Cardiol Therapeutics Following Promising Clinical Results and Strong Financial Position

CRDL

Press Releases

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index

"Emerging Innovators Transforming Global Markets: IPA, CRDL, KXIN, GNS, PRSO in Sectors"

Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

Spotlight on Undervalued Nasdaq Stocks: HCWB, CRDL, NIVF, SINT, APLM – A Must-Watch This Week!

Cardiol Therapeutics (Nasdaq: CRDL) Advances Orphan Drug Designation for CardiolRx™ at the American Heart Association…more stocks inside…

"Game-Changers to Watch CRDL, RMSG, WORX, PET and more…Innovative Companies inside"

Thanksgiving Week Oversold Stocks to Watch: CRDL, QBTS, PRSO, RGTI & More!

"Market Movers: CTOR, CTNT, PNPN.V, KITT, SHIM – More Stocks Inside to Watch"

"Cardiol Therapeutics (NASDAQ: CRDL) Heart Health Innovation – AVCO, GXAI, UPC, and More Stocks Driving Groundbreaking Advances"

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis

Comments

Cardiol Therapeutics

Interés en corto

Cardiol Therapeutics (NASDAQ:CRDL) Bolsa, Informe de interés en corto

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL